Short & Long-Term Side Effects of Ketamine on the Brain and Body

Most patients I see who have been using ketamine recreationally are surprised by two things. First, they had no idea ketamine could cause the level of bladder damage it does, because nobody warned them. Second, they assumed that because ketamine is used in clinics and hospitals, it must be safe at any dose. Those two misunderstandings are responsible for a lot of the harm I see in this population. The physiology of ketamine is genuinely interesting, but the clinical reality is that heavy use leaves some of the most distinctive and distressing organ damage I have encountered in addiction medicine.

What Ketamine Actually Does in Your Brain

Ketamine works primarily by blocking NMDA receptors. NMDA receptors (N-methyl-D-aspartate receptors) are the brain’s main gatekeepers for glutamate, the primary excitatory neurotransmitter. By blocking these receptors, ketamine essentially disrupts the normal flow of signals between neurons, which is why it produces dissociation, analgesia, and at higher doses, a complete detachment from reality.

That receptor block also triggers a surge in glutamate release from other neurons. The glutamate overflow then activates AMPA receptors and stimulates the release of BDNF, a protein called brain-derived neurotrophic factor that promotes new synaptic connections. That is the mechanism behind ketamine’s rapid antidepressant effect, which takes hold within hours rather than the weeks required by SSRIs.

At the same time, ketamine increases dopamine activity in the mesolimbic pathway, the brain’s reward circuit. That dopamine spike is modest compared to stimulants, but it is real, and it is part of why repeated use produces cravings and compulsive redosing.

The thing most people miss: ketamine also affects the default mode network, the brain’s resting-state system that generates the sense of a continuous, coherent self. Disrupting this network is what produces the “k-hole,” a dose-dependent state of near-complete ego dissolution that some users seek deliberately and others stumble into by accident.

Short-Term Side Effects of Ketamine

Short-term effects begin within one to five minutes of intravenous use, or within fifteen to twenty minutes of oral or intranasal use, and typically resolve within one to two hours.

Psychological and Perceptual Effects

The most immediate effects are perceptual and dissociative. You experience distortions in visual and auditory perception, a feeling of detachment from your body, and altered time perception. At recreational doses this can progress to full dissociation from surroundings and identity, the state users call “falling into the k-hole.”

Anxiety and paranoia can occur, especially in people with pre-existing anxiety disorders or when the drug is used in unfamiliar or unsafe environments. Agitation is common when the dissociative state is frightening rather than euphoric. Some users experience brief psychotic episodes that resolve as the drug clears, but these can be terrifying in the moment.

Physical Effects in the Short Term

On the body side, ketamine raises heart rate and blood pressure, which matters if you already have cardiovascular disease. It suppresses respiratory drive at high doses, though not as dramatically as opioids. It causes nystagmus (involuntary eye movements), muscle rigidity, and loss of coordination.

Nausea and vomiting are common, particularly with oral administration. Because ketamine also impairs the gag reflex at sedating doses, vomiting while heavily dissociated carries a real aspiration risk. This is one reason ketamine is always administered in a clinical setting with monitoring, and why recreational use without a sober companion is genuinely dangerous.

Long-Term Side Effects of Ketamine on the Brain

This is where the clinical picture gets more serious. The long-term neurological effects of heavy ketamine use are not speculative. They are well-documented and in some cases irreversible.

Memory and Cognitive Impairment

Chronic ketamine use damages the hippocampus and prefrontal cortex, the brain regions responsible for forming new memories and executive decision-making. The pattern I see in clinic is a specific and reproducible deficit: impaired episodic memory (the ability to remember specific events) combined with slowed processing speed and poor working memory.

A key study published in Addiction Biology demonstrated that frequent ketamine users showed significantly greater memory deficits than both occasional users and controls, and that these deficits persisted even after periods of abstinence. The damage appears to be dose-dependent, meaning that the more you use and the more often, the worse the cognitive impact.

Persistent Psychosis and Dissociation

Some heavy users develop what is clinically termed ketamine-induced psychosis, a state in which paranoia, thought disorganisation, and perceptual disturbances continue outside of active drug use. This is not common, but it is real, and it is more likely in people with a personal or family history of schizophrenia spectrum disorders.

Sub-threshold dissociation, a persistent background sense of unreality or depersonalisation, is more common than full psychosis. Patients describe feeling “not quite real” or “watching themselves from outside” for days or weeks after heavy use. This resolves with abstinence in most cases, but recovery can take months.

Depression and Mood Dysregulation After Stopping

This sounds counterintuitive given ketamine’s antidepressant properties. The reality is that the same NMDA receptor system that produces rapid antidepressant effects during use becomes dysregulated with chronic exposure. When you stop using, you can experience rebound depression that is often worse than any pre-existing mood disorder. The glutamate system becomes hypersensitive, the BDNF boost disappears, and dopamine signalling in the reward circuit is suppressed. The result is an anhedonic, low-motivation state that can last weeks to months.

You can read more about how drug-induced dopamine changes affect pleasure and motivation in our piece on dopamine desensitization and the recovery process.

Ketamine Bladder Syndrome — The Side Effect Most Users Do Not Know About

Ketamine bladder syndrome, also called ketamine-induced uropathy, is the most distinctive and destructive long-term complication of heavy ketamine use. It does not get nearly enough attention in mainstream drug information, and I consider that a serious public health failure.

The mechanism involves ketamine and its metabolite norketamine directly damaging the urothelium, the cell layer lining the bladder and upper urinary tract. This triggers chronic inflammation, submucosal fibrosis (scar tissue formation), and progressive loss of bladder capacity.

Symptoms begin with urinary frequency, urgency, and pain on urination. As the condition progresses, bladder capacity can drop to as little as 20-30 mL, compared to a normal functional capacity of 300-500 mL. At its worst, ketamine uropathy causes upper tract damage, hydronephrosis (kidney swelling from urine backflow), and renal failure.

The only treatment that halts progression is complete cessation of ketamine. Urological interventions such as hydrodistension, intravesical treatments, and in severe cases cystectomy (surgical bladder removal) manage the damage but do not reverse it. This is not a theoretical risk. In clinics treating heavy ketamine users in Southeast Asia, ketamine bladder syndrome is one of the most frequent presentations.

Ketamine Liver Damage — A Less Discussed but Serious Risk

Ketamine-associated cholangiopathy, liver damage linked to chronic ketamine use, is less widely known than bladder syndrome but clinically significant. It presents as elevated liver enzymes (particularly GGT and alkaline phosphatase), bile duct dilatation, and in severe cases, secondary biliary cirrhosis.

The mechanism is not fully established, but norketamine appears to have direct hepatotoxic effects on bile duct epithelial cells. The pattern resembles primary sclerosing cholangitis on imaging. Most cases I have seen improve significantly with abstinence, unlike bladder damage, though severe cases may require specialist hepatological management.

Any patient using ketamine heavily who experiences right upper quadrant pain, jaundice, or unexplained fatigue needs liver function tests.

Ketamine Addiction and Dependence — How It Develops

Ketamine does not produce the kind of physical dependence associated with opioids or alcohol. There is no severe physical withdrawal syndrome in the sense of seizures or autonomic instability. What it does produce is a strong psychological dependence driven by several mechanisms.

First, the dissociative and euphoric effects are highly reinforcing in certain users, particularly those with underlying depression, anxiety, or trauma. The drug reliably and rapidly removes psychological pain. That is an extremely powerful reinforcer.

Second, tolerance develops quickly. Users find they need larger doses to achieve the same dissociative state, which means escalating use and escalating exposure to the toxic metabolites that damage the bladder and liver.

Third, stopping produces the rebound depression and anhedonia described earlier. Using again immediately relieves these symptoms, which is a classic negative reinforcement cycle, using to escape withdrawal symptoms rather than to get high.

For a more detailed look at how ketamine compares to other substances in terms of addiction potential and neurobiology, see our article on ketamine addiction risks.

Ketamine Side Effects Compared to Other Dissociatives

Ketamine is sometimes grouped with other dissociatives like PCP (phencyclidine), DXM (dextromethorphan), and nitrous oxide. The dissociative mechanism is broadly shared, but the specific risk profiles are meaningfully different.

The bladder damage is unique to ketamine and its metabolites. No other dissociative has this profile. That makes ketamine’s long-term risk pattern distinctive even within this drug class.

Side Effects of Medical and Therapeutic Ketamine Use

Ketamine used at sub-anaesthetic doses in clinical settings, such as for treatment-resistant depression or as an adjunct in substance use treatment, carries a very different risk profile. Doses used in ketamine-assisted therapy are typically 0.5 mg/kg intravenously over 40 minutes, far below recreational doses, and administered in monitored environments.

At these doses, the main side effects are transient: dissociation and perceptual distortion during infusion, nausea in a minority of patients, transient blood pressure elevation, and mild post-infusion fatigue. Bladder damage at therapeutic doses and frequencies has not been established as a significant risk, though patients with pre-existing urinary symptoms should be screened carefully.

The controversy around medical ketamine use centres on whether repeated treatment courses can produce cognitive side effects or create pathways to misuse in vulnerable populations. These are legitimate clinical questions that are still being studied.

You can read more about the clinical context of ketamine-assisted therapy for substance use disorder at Phuket Island Rehab.

Who Is at Highest Risk for Severe Ketamine Side Effects

Not everyone who uses ketamine experiences severe side effects. The risk is not uniform, and knowing where it concentrates is useful.

Daily or near-daily users face the highest risk of bladder syndrome, cognitive impairment, and dependence. The research consistently shows a dose-frequency threshold: users who take ketamine more than four times per week over months are the group in whom bladder damage is most commonly documented.

People with pre-existing psychotic spectrum disorders or first-degree relatives with schizophrenia are at substantially higher risk for ketamine-induced psychotic episodes. This is not a contraindication that shows up on a package insert. It is a clinical reality.

People using ketamine to self-medicate depression, anxiety, or trauma carry elevated risk for psychological dependence. The drug works temporarily and powerfully on these symptoms, which makes it extremely easy to escalate use.

People who combine ketamine with alcohol, opioids, or benzodiazepines face the highest acute risk of respiratory depression and death. This combination is responsible for the majority of ketamine-related hospitalisations I am aware of in this region.

The DSM-5 does not list ketamine use disorder as a separate diagnostic category, but it falls under “Other Hallucinogen Use Disorder” and the criteria apply cleanly. If you are using ketamine more frequently than you intend, finding it hard to cut down, continuing despite urinary symptoms or mood problems, or using it to manage emotional pain rather than recreationally, that pattern meets clinical criteria for a use disorder. The cognitive symptoms, the bladder damage, and the rebound depression all worsen the longer use continues. This is not a phase that resolves on its own.

At Phuket Island Rehab, we treat ketamine use disorder with a structured programme that addresses both the physical complications and the psychological drivers of use. Our team includes physicians who can manage urological and hepatic complications alongside the addiction medicine and psychotherapy components of treatment. If you are somewhere in this pattern, reaching out is the practical next step.

Ketamine has a genuinely complex pharmacology. Its NMDA receptor antagonism produces effects that range from clinically valuable (rapid antidepressant action, anaesthesia) to seriously damaging (bladder destruction, cognitive fragmentation) depending entirely on dose, frequency, and context. Short-term side effects include dissociation, hallucinations, raised blood pressure, nausea, and in overdose, respiratory depression. Long-term effects of heavy use include memory and executive function deficits, persistent dissociation and mood dysregulation, ketamine bladder syndrome (which can progress to requiring surgical bladder removal), and ketamine-associated liver damage. Psychological dependence develops through a combination of powerful positive reinforcement and rebound dysphoria on cessation. The risk is not evenly distributed; daily or near-daily users, those with psychiatric vulnerabilities, and those combining ketamine with CNS depressants face the most serious consequences.

The practical takeaway is straightforward. Occasional, low-dose ketamine in a safe environment carries manageable acute risks. Frequent, high-dose use carries risks that are not manageable without stopping completely. Urinary symptoms are a red line. Once ketamine bladder syndrome takes hold, the window for full recovery narrows with every further use. Cognitive effects are partly reversible with sustained abstinence, but the process takes months, not days. If you are using ketamine to manage emotional pain, that pattern will almost certainly escalate, and treatment works better the earlier it starts.

As John A. Smith of Phuket Island Rehab puts it: “The patients who come to me with bladder damage from ketamine almost always say the same thing: they wish someone had told them this was coming. The information exists. The problem is that most people using ketamine recreationally never see it, and by the time the symptoms appear, months of irreversible damage have already been done.”

What are the most dangerous side effects of ketamine?

The most dangerous acute side effect of ketamine is respiratory depression, which can be fatal when ketamine is combined with alcohol, opioids, or benzodiazepines. In the long term, the most serious side effect is ketamine bladder syndrome, which can progress to surgical bladder removal and kidney damage with continued use. Both risks are dose-dependent and substantially higher at recreational compared to therapeutic doses.

How quickly does ketamine damage the bladder?

Bladder damage can develop within months of frequent heavy use, though the timeline varies considerably between individuals. The pattern most commonly documented involves daily or near-daily use over three to six months before symptoms appear. Early symptoms like urinary urgency and frequency are reversible with complete abstinence. Waiting until pain or bleeding appears means some damage is likely already permanent.

Does ketamine cause permanent brain damage?

Heavy chronic ketamine use causes measurable damage to the hippocampus and prefrontal cortex that can persist beyond the period of use. Research shows that memory deficits and processing speed impairments remain detectable even after abstinence, though most studies show partial recovery over months to years. Whether any damage is truly permanent depends on duration and intensity of use; at therapeutic clinical doses, permanent brain damage has not been established.

Can you get addicted to ketamine?

Yes. Ketamine produces psychological dependence through dopamine release in the mesolimbic reward circuit, rapid reinforcement of dissociative effects, and a rebound depression on cessation that makes stopping feel intolerable. Physical withdrawal (seizures, severe autonomic instability) is not a feature of ketamine dependence, but the psychological compulsion to continue use despite obvious harm meets DSM-5 criteria for a use disorder in many heavy users.

What are the side effects of ketamine used for depression?

At the sub-anaesthetic doses used for treatment-resistant depression (typically 0.5 mg/kg IV over 40 minutes), side effects are transient and manageable. During infusion you will likely experience dissociation, altered perception, and possibly nausea. Blood pressure rises temporarily. These effects resolve within one to two hours. Bladder damage and cognitive impairment at therapeutic doses and frequencies have not been established as clinically significant risks in the current evidence base.

What happens when you mix ketamine with alcohol?

Combining ketamine with alcohol produces additive central nervous system depression through separate but complementary mechanisms: alcohol enhances GABA-A receptor activity while ketamine blocks NMDA receptors, and both suppress respiratory drive. The result is a significantly higher risk of respiratory failure than either substance alone. This combination is responsible for a large proportion of ketamine-related emergency presentations. It is not a manageable risk with harm reduction measures. It should be avoided completely.

How long do ketamine side effects last?

Acute side effects from a single dose resolve within one to four hours. The antidepressant effect, if it occurs, lasts days to several weeks. Cognitive side effects from chronic use can persist for months after stopping. Bladder damage, once established at moderate or severe stages, is only partially reversible and may be permanent. Rebound depression after stopping chronic use typically peaks in the first one to three weeks and gradually resolves over months with proper support.